Clinical Trials Browser

Phase 2/3 × Peripheral Nervous System Diseases × Paclitaxel × Clear all

NCT05189535 2024-01-23

"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"

Phase 2/3 Completed

Breast Neoplasms, Peripheral Nervous System Diseases